INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $97,828 | -46.4% | 119,302 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $182,408 | -9.7% | 116,928 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $202,000 | +13.5% | 117,353 | +14.1% | 0.00% | 0.0% |
Q2 2022 | $178,000 | -51.8% | 102,881 | +0.2% | 0.00% | -50.0% |
Q1 2022 | $369,000 | -32.7% | 102,655 | -6.6% | 0.00% | -33.3% |
Q4 2021 | $548,000 | -32.3% | 109,880 | -2.9% | 0.00% | -25.0% |
Q3 2021 | $810,000 | -24.6% | 113,168 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $1,074,000 | +7.2% | 115,857 | +7.3% | 0.00% | 0.0% |
Q1 2021 | $1,002,000 | +22.8% | 107,944 | +17.1% | 0.00% | +33.3% |
Q4 2020 | $816,000 | -25.0% | 92,167 | -1.7% | 0.00% | -40.0% |
Q3 2020 | $1,088,000 | -54.1% | 93,755 | +6.6% | 0.01% | -54.5% |
Q2 2020 | $2,371,000 | +467.2% | 87,989 | +56.7% | 0.01% | +450.0% |
Q1 2020 | $418,000 | +117.7% | 56,169 | -3.2% | 0.00% | +100.0% |
Q4 2019 | $192,000 | +60.0% | 58,047 | -0.8% | 0.00% | – |
Q3 2019 | $120,000 | -30.2% | 58,536 | +0.3% | 0.00% | -100.0% |
Q2 2019 | $172,000 | -16.9% | 58,352 | +5.3% | 0.00% | 0.0% |
Q1 2019 | $207,000 | -5.0% | 55,425 | +1.5% | 0.00% | 0.0% |
Q4 2018 | $218,000 | -28.8% | 54,589 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $306,000 | +44.3% | 55,009 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $212,000 | -13.5% | 54,017 | +3.7% | 0.00% | 0.0% |
Q1 2018 | $245,000 | +7.9% | 52,073 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $227,000 | -33.6% | 54,874 | +1.7% | 0.00% | 0.0% |
Q3 2017 | $342,000 | +4.3% | 53,963 | +29.1% | 0.00% | 0.0% |
Q2 2017 | $328,000 | +21.5% | 41,794 | +2.3% | 0.00% | 0.0% |
Q1 2017 | $270,000 | +1.9% | 40,856 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $265,000 | -99.9% | 38,161 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $356,583,000 | +1.0% | 38,260 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $352,986,000 | -8.1% | 38,202 | -13.3% | 0.00% | -50.0% |
Q1 2016 | $384,000,000 | +25.5% | 44,062 | -2.8% | 0.00% | +100.0% |
Q4 2015 | $306,000,000 | +87079.5% | 45,328 | -25.3% | 0.00% | -50.0% |
Q3 2015 | $351,000 | -99.9% | 60,647 | +0.9% | 0.00% | 0.0% |
Q2 2015 | $490,587,000 | +16.2% | 60,121 | +16.2% | 0.00% | 0.0% |
Q1 2015 | $422,198,000 | -12.2% | 51,740 | -1.3% | 0.00% | 0.0% |
Q4 2014 | $481,088,000 | -12.2% | 52,406 | -5.8% | 0.00% | 0.0% |
Q3 2014 | $548,232,000 | -8.0% | 55,658 | +1.0% | 0.00% | -33.3% |
Q2 2014 | $595,761,000 | – | 55,112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sante Capital Fund, LP | 115,637 | $1,072,000 | 0.44% |
Defender Capital, LLC. | 135,466 | $1,255,000 | 0.42% |
Green Alpha Advisors, LLC | 62,566 | $580,000 | 0.40% |
Harvest Investment Services, LLC | 51,239 | $474,000 | 0.20% |
SEVEN EIGHT CAPITAL, LP | 118,270 | $1,096,000 | 0.15% |
Cedar Brook Financial Partners, LLC | 54,500 | $505,000 | 0.15% |
WASATCH ADVISORS LP | 3,576,706 | $33,156,000 | 0.14% |
Banco BTG Pactual S.A. | 20,000 | $185,000 | 0.12% |
Keystone Financial Group | 60,712 | $563,000 | 0.10% |
Virtus ETF Advisers LLC | 25,105 | $233,000 | 0.10% |